Thursday, 9 March 2017

Biodefense Market 2017 Global Significant Growth, Technological Advancement & Opportunities to 2022

Biodefense Market 2017




Summary

Wiseguyreports.Com Adds “Biodefense -Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Suppliers and Forecast to 2021” To Its Research Database

This report studies the global Biodefense market, analyzes and researches the Biodefense development status and forecast in United States, EU, Japan, China, India and Southeast Asia.


This report focuses on the top players in global market, like
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Biodefense can be split into
Anthrax
Smallpox
Botulism
Radiation/nuclear
Other

Market segment by Application, Biodefense can be split into
Application 1
Application 2


Key Points in Table of Content:

Global Biodefense Market Size, Status and Forecast 2022
1 Industry Overview of Biodefense
1.1 Biodefense Market Overview
1.1.1 Biodefense Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biodefense Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Biodefense Market by Type
1.3.1 Anthrax
1.3.2 Smallpox
1.3.3 Botulism
1.3.4 Radiation/nuclear
1.3.5 Other
1.4 Biodefense Market by End Users/Application
1.4.1 Application 1
1.4.2 Application 2
…..

3 Company (Top Players) Profiles 
3.1 Emergent Biosolutions
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biodefense Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Hytest
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biodefense Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biodefense Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biodefense Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 PharmAthene
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biodefense Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bavarian Nordic
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biodefense Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 SIGA Technologies
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biodefense Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Arbutus Biopharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biodefense Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 DynPort Vaccine
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biodefense Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Xoma Corporation


Continued...                    
                                                                                 
Contact Us:
NORAH TRENT               
Ph: +1-646-845-9349 (US)  
Ph: +44 208 133 9349 (UK)



Click Here For More Details

No comments:

Post a Comment